SCHEMBL4631634

SCHEMBL4631634

CCOC(=O)c1cc(NC(=O)COCC(=O)NCCNC(=O)OCC2c3ccccc3-c3ccccc32)ccc1-c1c2ccc(=O)cc-2oc2cc(OCC(=O)OC(C)(C)C)ccc12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.38
HPGD P15428 4/20 0.38
MAPT P10636 3/20 0.38
RXFP1 Q9HBX9 1/20 0.38
KDM4E B2RXH2 6/20 0.36
CA12 O43570 5/20 0.36
CA1 P00915 5/20 0.36
CA2 P00918 5/20 0.36
CA9 Q16790 4/20 0.36
LMNA P02545 1/20 0.35
GLA P06280 1/20 0.35
GAA P10253 1/20 0.35
TP53 P04637 1/20 0.35
POLB P06746 1/20 0.35
PTGER3 P43115 1/20 0.34
CA4 P22748 1/20 0.34
CA5A P35218 1/20 0.34
CA7 P43166 1/20 0.34
CA5B Q9Y2D0 1/20 0.34
FKBP1A P62942 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4630833 0.94 ALDH1A1 (0.38) ALDH1A1HPGDMAPTRXFP1KDM4E
SCHEMBL4937655 0.90 ALDH1A1 (0.37) ALDH1A1HPGDMAPTRXFP1KDM4E
SCHEMBL4631632 0.87 ALDH1A1 (0.37) ALDH1A1HPGDMAPTRXFP1KDM4E
SCHEMBL4630755 0.85 MAPT (0.42) ALDH1A1HPGDMAPTRXFP1KDM4E
SCHEMBL4630116 0.84 CA9 (0.38) ALDH1A1HPGDMAPTRXFP1KDM4E
SCHEMBL4630010 0.81 CA9 (0.42) ALDH1A1HPGDMAPTRXFP1KDM4E
SCHEMBL4631742 0.81 MAPT (0.42) ALDH1A1HPGDMAPTRXFP1KDM4E
SCHEMBL4631207 0.80 PTGER3 (0.37) ALDH1A1HPGDMAPTRXFP1KDM4E
SCHEMBL4630113 0.80 CA9 (0.36) MAPTRXFP1CA12CA1CA2
SCHEMBL4631325 0.76 KDM4E (0.41) ALDH1A1HPGDMAPTRXFP1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080275215-A1 Fluorescein-Based Compounds And Their Use For Peptide Synthesis COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) 2008-11-06 US disclosed
EP-1749870-B1 Fluorescein-based compounds and their use for peptide synthesis COMMISSARIAT ENERGIE ATOMIQUE (FR) 2008-05-14 EP disclosed
WO-2007029122-A2 FLUORESCEIN-BASED COMPOUNDS AND THEIR USE FOR PEPTIDE SYNTHESIS COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) 2007-03-15 WO disclosed
EP-1749870-A1 Fluorescein-based compounds and their use for peptide synthesis COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) 2007-02-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080275215-A1 Fluorescein-Based Compounds And Their Use For Peptide Synthesis DNPEP, ANPEP, PEPD ALDH1A1 3716/4885HPGD 2522/4885MAPT 2288/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.